| Name | Eligible | Study sites | More information |
|---|---|---|---|
| ABC008 | Adults with inclusion body myositis (IBM) | 12 sites in US | More Details; Abcuro/Syneos 617-865-5079 NCT05721573 |
| Brepocitinib (VALOR) | Adults with dermatomyositis (DM) | >30 sites in US >50 sites abroad | More Details; Proivant 646-402-6892 NCT05437263 |
| Daxdilimab | Adults with DM or anti-synthetase inflammatory myositis (ASIM) | 13 sites in US 32 sites abroad | More details; Horizon Therapeutics 1-866-479-6742 NCT05669014 |
| Efgartigimod (ALKIVIA) |
Adults with IIM | 10 sites in US 8 sites abroad | More Details; argenx 857-350-4834 NCT05523167 |
| Enpatoran (NEPTUNIA) | Adults with DM or PM | Orlando, FL Austin, TX | More details; EMD Serono 888-275-7376 NCT05523167 |
| GLPG3667 | Adults with dermatomyositis (DM) | 4 sites in US | More details; Galapagos NV 321-534-2900 NCT05695950 |
| IgPro20 (Hizentra) | Adults with active dermatomyositis (DM) | 76 sites worldwide | More details; CSL Behring 610-878-4000 NCT04044690 |
| Nintedanib (MINT) | Adults with ILD and myositis | 14 sites in US | More details MINTcc@pitt.edu 412-648-9989 NCT05799755 |
| Nipocalimab (SPIREA) | Adults with IIM | 27 sites worldwide | More details; Janssen 844-434-4210 NCT05379634 |
| PF-06823859 | Adults with active DM or PM | 18 sites in US | More details; Pfizer 800-718-1021 NCT05895786 |
| Ravulizumab | Adults with dermatomyositis (DM) | 10 sites in US 29 sites abroad | More details; Alexion 855-752-2356 NCT04999020 |
| Sirolimus | Adults with inclusion body myositis (IBM) | 2 sites in US 7 sites in Australia | More details; 913-945-9926 NCT04789070 |